Skip to content

Nationwide Japanese prostate cancer outcome study of permanent Iodine-125 seed implantation (J-POPS): Medical record-based longevity survey

Nationwide Japanese prostate cancer outcome study of permanent Iodine-125 seed implantation (J-POPS): Paper questionnaire sent by mail-based longevity survey - J-POPS: Paper questionnaire sent by mail-based longevity survey

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000040809
Enrollment
500
Registered
2020-06-17
Start date
2020-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

None listed

Sponsors

The Japanese Prostate Permanent Seed Implantation Study Group
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients enrolled in Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation

Exclusion criteria

Exclusion criteria: Patients without informed consent

Design outcomes

Primary

MeasureTime frame
Overall survival

Secondary

MeasureTime frame
biochemical progression-free survival, clinical progression-free survival, freedom from treatment failure, time to biochemical progression, time to clinical progression, disease-specific survival, metastasis-free survival,time to castration resistant prostate cancer

Countries

Japan

Contacts

Public ContactNakai Yasushi

Nara Medical University Department of Urology

nakaiyasushi@naramed-u.ac.jp0744-22-3051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026